NanoViricides, Inc. NNVC
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.77% | 10.42% | -24.40% | 14.83% | 5.45% |
| Total Depreciation and Amortization | 0.08% | -2.63% | 0.23% | -17.57% | -15.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -29.92% | -63.82% | 293.60% | -4.40% | -11.21% |
| Change in Net Operating Assets | 44.97% | 10.52% | -1,990.48% | -95.35% | 842.80% |
| Cash from Operations | -9.91% | 5.81% | -28.60% | 6.35% | 14.52% |
| Capital Expenditure | -- | -- | 100.00% | -726.47% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | -726.47% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 387.79% | 71.03% | 26.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25,514.93% | -100.11% | 387.79% | 71.03% | 26.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.37% | -148.13% | 1,029.75% | 56.01% | 30.48% |